Explore our specialized services spanning chromatographic method establishment, in vitro bioassays, Phase 1-4 clinical evaluation, and high-yield active molecule screening.
Navigating the transition from experiential medicine to precise, molecular-level natural pharmacotherapy through systemic multi-target pharmacology and standardized phytochemical engineering.
The global pharmaceutical and nutraceutical sectors are witnessing a structural transition. For centuries, Classic Traditional Chinese Medicine (TCM) formulas—such as Xiao Chai Hu Tang, Liu Wei Di Huang Wan, and Yin Qiao San—have demonstrated multi-component therapeutic efficacy across broad patient populations. However, traditional empirical applications historically encountered commercial limitations in international markets due to challenges in active molecule characterization, batch-to-batch variation, and complex regulatory divergence across jurisdictions.
As an authoritative China Classic Traditional Chinese Medicine Formulas Manufacturer & Supplier, MedGence (Yineng Pharma) operates at the nexus of empirical historical knowledge and advanced analytical biotechnology. Based in Changsha, Hunan, MedGence provides end-to-end Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services. Backed by an interdisciplinary roster of over 300 biomedical scientists, analytical chemists, and pharmacological specialists, we have systematically evaluated over 83 classic TCM formulas, registered 56 hospital preparations, developed 22 novel natural chemical entities, and standardized quality profiles for approximately 400 single-herb botanical matrices.
Converting macro-level empirical herbal synergies into verifiable chromatographic fingerprint profiles (HPLC, HPTLC, GC-MS), ensuring absolute chemical repeatability matching USP & Ph. Eur standards.
Decoding the complex multi-target mechanisms of compound herbal recipes using computational biology, molecular docking simulations, and proteomic target deconvolution.
Guiding botanical drug candidates and health preparations through OECD-compliant GLP toxicological evaluations, animal efficacy models, and GCP-compliant Phase I-IV trials.
Years of Dedicated Natural Medicine R&D
Senior Research Scientists & Lab Staff
Classic TCM Formulas Fully Modernized
Single-Herb Quality Standards Established
Bridging regional statutory pathways to convert traditional prescription assets into global nutraceutical blockbusters and FDA-cleared botanical drugs.
The international landscape for Traditional Chinese Medicine formulations has expanded beyond ethnic enclaves into mainstream clinical therapeutics and premium functional nutrition. Regulatory agencies across tier-1 markets have introduced specific botanical frameworks acknowledging the complex multi-ingredient composition of natural extracts, moving away from the simplistic requirement of isolated single-molecule synthetic APIs.
| Regulatory Framework / Region | Primary Regulatory Focus | Technical Thresholds | MedGence Enabling Capabilities |
|---|---|---|---|
| United States (US FDA) Botanical Drug Guidance (CDER) & DSHEA |
Therapeutic efficacy, batch-to-batch chemical consistency, CMC controls without single-molecule purity. | Clinically validated endpoints, raw material provenance, toxicological safety packages, Phase I-III. | IND-enabling preclinical packages, chromatographic fingerprint comparability studies, multi-batch chemometric modeling. |
| European Union (EMA) HMPC Herbal Monographs & Well-Established Use |
Documented safety history (15-30 years), heavy metal and pesticide thresholds (Ph. Eur.), active vs. marker substances. | Stringent residual solvent rules, elemental impurity limits (ICH Q3D), DNA barcoding for species identity. | EP 2.8.13 pesticide compliance, high-resolution HPTLC species verification, pilot extraction under GMP principles. |
| Australia (TGA) Listed & Registered Complementary Medicines |
Evidence level assurance, GMP compliance across all supply chain tiers, stringent ingredient permissible lists. | Manufacturing site audits, strict microbial and mycotoxin limits, clinical claim substantiation. | End-to-end analytical assay documentation, stability study packages (ICH guidelines), validated bioassay reports. |
| East Asia & ASEAN Hospital Formulations & Over-The-Counter (OTC) |
Direct therapeutic integration, modernization of ancient pharmacopeial recipes into modern dosage forms. | Heavy metal testing, extract dissolution profiling, bioavailability optimization. | 56 registered hospital preparation dossiers, advanced granulated dosage technology, instantized soluble extracts. |
Demand is driven by consumer saturation with synthetic pharmaceuticals and a growing preference for multi-target therapies in managing chronic, lifestyle-induced indications such as non-alcoholic fatty liver disease (NAFLD), metabolic syndrome, chronic inflammatory conditions, neurodegenerative cognitive decline, and immune senescence. Classic TCM formulas uniquely address these multifactorial etiologies by targeting multiple physiological cascades simultaneously.
Securing superior potency, purity, and environmental stability through geo-authentic botanical procurement, GAP certified bases, and vertically integrated processing.
Botanical potency fluctuates drastically based on microclimates, soil mineralization, and elevation. We enforce rigorous Daodi (geo-authentic) sourcing contracts across native provinces—from Panax ginseng in Jilin to Astragalus in Shanxi and Angelica sinensis in Gansu.
Active secondary metabolites vary significantly by season. Our analytical platforms quantify marker density across vegetative cycles, determining the optimal harvest window to maximize active yields and minimize inactive ballast materials.
Moving beyond open-vat boiling to dynamic counter-current extraction, multi-stage ceramic membrane filtration, macroporous resin absorption, and low-temperature vacuum crystallization for complete active retention.
Re-engineering classic botanical matrices to fit modern consumer lifestyles, dosage requirements, and regional health claim frameworks.
Extract powders and microencapsulated granules formulated into ready-to-mix drink powders, effervescent tablets, functional gummies, and liquid wellness shots targeting fatigue relief, gut microbiome balance, and adaptogenic stress response.
Providing high-purity fractions, active marker enrichments, and complete CMC documentation packages for clients advancing prescription drug candidates through US FDA IND/NDA or EU Well-Established Use filings.
Water-soluble and lipid-soluble active ingredients with verified anti-inflammatory, anti-tyrosinase, skin-barrier restoration, and photo-aging protective properties backed by rigorous in vitro keratinocyte and fibroblast assays.
Modernized combinations such as modified Shen Ling Bai Zhu San or berberine-polysaccharide complexes formulated for cellular autophagy induction, AMPK activation, and steady glycemic response management.
Deploying cutting-edge bio-computational and micro-carrier technologies to overcome classical limitations of natural medicine bioavailability and yield economics.
Utilizing high-performance deep neural networks trained on proprietary chromatographic libraries and clinical databases to predict ligand binding affinities and discover novel indications for traditional herbal pairings.
Overcoming the low oral bioavailability of poorly soluble botanical constituents (such as curcuminoids, flavonoids, and ginsenosides) via phospholipid complexation, self-emulsifying drug delivery systems (SEDDS), and polymeric nanoparticle encapsulation.
Integrating microbial metabolic engineering and enzymatic biotransformation to produce rare ginsenosides (such as Rg3, Rh2), astragaloside IV derivatives, and structurally complex saponins at commercial scale without exhausting scarce wild plant populations.
Eliminating market entry risks through exhaustive impurity testing, non-disclosure protocols, and strict adherence to international safety ceilings.
Every commercial and clinical batch undergoes screening across 500+ pesticide residues (compliant with USP <561> and EP 2.8.13), elemental heavy metals (ICP-MS for Lead, Cadmium, Arsenic, Mercury), aflatoxins, pyrrolizidine alkaloids, and residual ethylene oxide (EtO).
Operating strictly under non-disclosure entrusted CDMO frameworks. Clients retain 100% intellectual property ownership of proprietary formulation ratios, customized extraction parameters, and bioassay datasets.
We supply comprehensive technical packages including Method Validation Protocols (ICH Q2(R1)), Certificate of Analysis (CoA) with raw spectra, accelerated stability studies (40°C/75% RH), and regulatory registration support for seamless customs clearance.
Over 14+ years of industrial R&D collaboration with China's foremost state-level pharmaceutical manufacturers, university hospitals, and clinical research institutions.
Tongrentang Group
CR Sanjiu Medical
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtze River Pharma
Beihai Gofar
Humanwell Group
SCIMYTH Pharma
Shandong Hanfang
Luoxin Pharma
Zhongsheng Pharma
Apeloa Pharma
Heng Chang Pharma
Baotou TCM Co.
Kamp Medicine
Shuguang Hospital
Direct technical answers addressing active compound extraction ratios, fingerprint consistency, regulatory filing support, and intellectual property custody.
Select your target research service or extract specification below to initiate project scoping, custom method establishment, or commercial CDMO procurement.
